PodcastIntel
Sign in Get Started Free
Urology Times
Urology Times

NeoBLAST trial tests active surveillance after complete response in MIBC

Sep 4, 2026 · 0:05:35
Listen to Episode
✨ AI Summary
  • NeoBLAST trial investigates active surveillance for MIBC patients.
  • Complete response to neoadjuvant therapy is key for eligibility.
  • The trial aims to replace surgery or radiation with surveillance.

More from Urology Times

Urology Times
When surgery may be needed for prolonged ischemic priapism
Oct 12, 2026 · 0:02:34
Urology Times
Study compares PSMA-PET radiopharmaceuticals in prostate cancer recurrence
Oct 12, 2026 · 0:03:53
Urology Times
How can urologists separate personalized medicine from marketing?
Oct 9, 2026 · 0:04:29
Urology Times
Why ctDNA serves as a rule-out in NeoBLAST's response assessment
Oct 8, 2026 · 0:06:56
View all episodes →

Get AI Summaries for Every New Episode

Subscribe to Urology Times and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →